Rina Plattner
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma (NCT04903119) | Rina Plattner | 2022-06-01 |
Track Rina Plattner automatically
Every clearance here is in the API, with alerts when new ones post.